Alzheimer’s Disease Neuroimaging Initiative. Amyloid PET Quantification Via End-to-End Training of a Deep Learning

a year ago   •   1 min read

By Portrai

Nucl Med Mol Imaging. 2019;53(5):340-348.

Abstract

Purpose: Although quantification of amyloid positron emission tomography (PET) is important for evaluating patients with cognitive impairment, its routine clinical use is hampered by complicated preprocessing steps and required MRI. Here, we suggested a one-step quantification based on deep learning using native-space amyloid PET images of different radiotracers acquired from multiple centers.

Methods: Amyloid PET data of the Alzheimer Disease Neuroimaging Initiative (ADNI) were used for this study. A training/validation consists of 850 florbetapir PET images. Three hundred sixty-six florbetapir and 89 florbetaben PET images were used as test sets to evaluate the model. Native-space amyloid PET images were used as inputs, and the outputs were standardized uptake value ratios (SUVRs) calculated by the conventional MR-based method.

Results: The mean absolute errors (MAEs) of the composite SUVR were 0.040, 0.060, and 0.050 of training/validation and test sets for florbetapir PET and a test set for florbetaben PET, respectively. The agreement of amyloid positivity measured by Cohen's kappa for test sets of florbetapir and florbetaben PET were 0.87 and 0.89, respectively.

Conclusion: We suggest a one-step quantification method for amyloid PET via a deep learning model. The model is highly reliable to quantify the amyloid PET regardless of multicenter images and various radiotracers.

Keywords: Alzheimer’s disease; Amyloid PET; Convolutional neural network; Deep learning; Quantification.

Authors

Kim JY, Suh HY, Ryoo HG, Oh D, Choi H, Paeng JC, Cheon GJ, Kang KW, Lee DS

Spread the word

Keep reading